Cargando…
Clinical outcomes of patients receiving prolonged extracorporeal membrane oxygenation for respiratory support
BACKGROUND: There are limited data regarding prolonged extracorporeal membrane oxygenation (ECMO) support, despite increase in ECMO use and duration in patients with respiratory failure. The objective of this study was to investigate the outcomes of severe acute respiratory failure patients supporte...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535699/ https://www.ncbi.nlm.nih.gov/pubmed/31090503 http://dx.doi.org/10.1177/1753466619848941 |
_version_ | 1783421607298990080 |
---|---|
author | Na, Soo Jin Jung, Jae-Seung Hong, Sang-Bum Cho, Woo Hyun Lee, Sang-Min Cho, Young-Jae Park, Sunghoon Koo, So-My Park, Seung Yong Chang, Youjin Kang, Byung Ju Kim, Jung-Hyun Oh, Jin Young Park, So Hee Yoo, Jung-Wan Sim, Yun Su Jeon, Kyeongman |
author_facet | Na, Soo Jin Jung, Jae-Seung Hong, Sang-Bum Cho, Woo Hyun Lee, Sang-Min Cho, Young-Jae Park, Sunghoon Koo, So-My Park, Seung Yong Chang, Youjin Kang, Byung Ju Kim, Jung-Hyun Oh, Jin Young Park, So Hee Yoo, Jung-Wan Sim, Yun Su Jeon, Kyeongman |
author_sort | Na, Soo Jin |
collection | PubMed |
description | BACKGROUND: There are limited data regarding prolonged extracorporeal membrane oxygenation (ECMO) support, despite increase in ECMO use and duration in patients with respiratory failure. The objective of this study was to investigate the outcomes of severe acute respiratory failure patients supported with prolonged ECMO for more than 28 days. METHODS: Between January 2012 and December 2015, all consecutive adult patients with severe acute respiratory failure who underwent ECMO for respiratory support at 16 tertiary or university-affiliated hospitals in South Korea were enrolled retrospectively. The patients were divided into two groups: short-term group defined as ECMO for ⩽28 days and long-term group defined as ECMO for more than 28 days. In-hospital and 6-month mortalities were compared between the two groups. RESULTS: A total of 487 patients received ECMO support for acute respiratory failure during the study period, and the median support duration was 8 days (4–20 days). Of these patients, 411 (84.4%) received ECMO support for ⩽28 days (short-term group), and 76 (15.6%) received support for more than 28 days (long-term group). The proportion of acute exacerbation of interstitial lung disease as a cause of respiratory failure was higher in the long-term group than in the short-term group (22.4% versus 7.5%, p < 0.001), and the duration of mechanical ventilation before ECMO was longer (4 days versus 1 day, p < 0.001). The hospital mortality rate (60.8% versus 69.7%, p = 0.141) and the 6-month mortality rate (66.2% versus 74.0%, p = 0.196) were not different between the two groups. ECMO support longer than 28 days was not associated with hospital mortality in univariable and multivariable analyses. CONCLUSIONS: Short- and long-term survival rates among patients receiving ECMO support for more than 28 days for severe acute respiratory failure were not worse than those among patients receiving ECMO for 28 days or less. |
format | Online Article Text |
id | pubmed-6535699 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-65356992019-06-14 Clinical outcomes of patients receiving prolonged extracorporeal membrane oxygenation for respiratory support Na, Soo Jin Jung, Jae-Seung Hong, Sang-Bum Cho, Woo Hyun Lee, Sang-Min Cho, Young-Jae Park, Sunghoon Koo, So-My Park, Seung Yong Chang, Youjin Kang, Byung Ju Kim, Jung-Hyun Oh, Jin Young Park, So Hee Yoo, Jung-Wan Sim, Yun Su Jeon, Kyeongman Ther Adv Respir Dis Original Research BACKGROUND: There are limited data regarding prolonged extracorporeal membrane oxygenation (ECMO) support, despite increase in ECMO use and duration in patients with respiratory failure. The objective of this study was to investigate the outcomes of severe acute respiratory failure patients supported with prolonged ECMO for more than 28 days. METHODS: Between January 2012 and December 2015, all consecutive adult patients with severe acute respiratory failure who underwent ECMO for respiratory support at 16 tertiary or university-affiliated hospitals in South Korea were enrolled retrospectively. The patients were divided into two groups: short-term group defined as ECMO for ⩽28 days and long-term group defined as ECMO for more than 28 days. In-hospital and 6-month mortalities were compared between the two groups. RESULTS: A total of 487 patients received ECMO support for acute respiratory failure during the study period, and the median support duration was 8 days (4–20 days). Of these patients, 411 (84.4%) received ECMO support for ⩽28 days (short-term group), and 76 (15.6%) received support for more than 28 days (long-term group). The proportion of acute exacerbation of interstitial lung disease as a cause of respiratory failure was higher in the long-term group than in the short-term group (22.4% versus 7.5%, p < 0.001), and the duration of mechanical ventilation before ECMO was longer (4 days versus 1 day, p < 0.001). The hospital mortality rate (60.8% versus 69.7%, p = 0.141) and the 6-month mortality rate (66.2% versus 74.0%, p = 0.196) were not different between the two groups. ECMO support longer than 28 days was not associated with hospital mortality in univariable and multivariable analyses. CONCLUSIONS: Short- and long-term survival rates among patients receiving ECMO support for more than 28 days for severe acute respiratory failure were not worse than those among patients receiving ECMO for 28 days or less. SAGE Publications 2019-05-15 /pmc/articles/PMC6535699/ /pubmed/31090503 http://dx.doi.org/10.1177/1753466619848941 Text en © The Author(s), 2019 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Na, Soo Jin Jung, Jae-Seung Hong, Sang-Bum Cho, Woo Hyun Lee, Sang-Min Cho, Young-Jae Park, Sunghoon Koo, So-My Park, Seung Yong Chang, Youjin Kang, Byung Ju Kim, Jung-Hyun Oh, Jin Young Park, So Hee Yoo, Jung-Wan Sim, Yun Su Jeon, Kyeongman Clinical outcomes of patients receiving prolonged extracorporeal membrane oxygenation for respiratory support |
title | Clinical outcomes of patients receiving prolonged extracorporeal membrane oxygenation for respiratory support |
title_full | Clinical outcomes of patients receiving prolonged extracorporeal membrane oxygenation for respiratory support |
title_fullStr | Clinical outcomes of patients receiving prolonged extracorporeal membrane oxygenation for respiratory support |
title_full_unstemmed | Clinical outcomes of patients receiving prolonged extracorporeal membrane oxygenation for respiratory support |
title_short | Clinical outcomes of patients receiving prolonged extracorporeal membrane oxygenation for respiratory support |
title_sort | clinical outcomes of patients receiving prolonged extracorporeal membrane oxygenation for respiratory support |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535699/ https://www.ncbi.nlm.nih.gov/pubmed/31090503 http://dx.doi.org/10.1177/1753466619848941 |
work_keys_str_mv | AT nasoojin clinicaloutcomesofpatientsreceivingprolongedextracorporealmembraneoxygenationforrespiratorysupport AT jungjaeseung clinicaloutcomesofpatientsreceivingprolongedextracorporealmembraneoxygenationforrespiratorysupport AT hongsangbum clinicaloutcomesofpatientsreceivingprolongedextracorporealmembraneoxygenationforrespiratorysupport AT chowoohyun clinicaloutcomesofpatientsreceivingprolongedextracorporealmembraneoxygenationforrespiratorysupport AT leesangmin clinicaloutcomesofpatientsreceivingprolongedextracorporealmembraneoxygenationforrespiratorysupport AT choyoungjae clinicaloutcomesofpatientsreceivingprolongedextracorporealmembraneoxygenationforrespiratorysupport AT parksunghoon clinicaloutcomesofpatientsreceivingprolongedextracorporealmembraneoxygenationforrespiratorysupport AT koosomy clinicaloutcomesofpatientsreceivingprolongedextracorporealmembraneoxygenationforrespiratorysupport AT parkseungyong clinicaloutcomesofpatientsreceivingprolongedextracorporealmembraneoxygenationforrespiratorysupport AT changyoujin clinicaloutcomesofpatientsreceivingprolongedextracorporealmembraneoxygenationforrespiratorysupport AT kangbyungju clinicaloutcomesofpatientsreceivingprolongedextracorporealmembraneoxygenationforrespiratorysupport AT kimjunghyun clinicaloutcomesofpatientsreceivingprolongedextracorporealmembraneoxygenationforrespiratorysupport AT ohjinyoung clinicaloutcomesofpatientsreceivingprolongedextracorporealmembraneoxygenationforrespiratorysupport AT parksohee clinicaloutcomesofpatientsreceivingprolongedextracorporealmembraneoxygenationforrespiratorysupport AT yoojungwan clinicaloutcomesofpatientsreceivingprolongedextracorporealmembraneoxygenationforrespiratorysupport AT simyunsu clinicaloutcomesofpatientsreceivingprolongedextracorporealmembraneoxygenationforrespiratorysupport AT jeonkyeongman clinicaloutcomesofpatientsreceivingprolongedextracorporealmembraneoxygenationforrespiratorysupport |